The effects of maternal hypercortisonism and hypervitaminosis D2 on fetal osteogenesis and ossification in rats.
D000014:Abnormalities, Drug-Induced; D000284:Administration, Oral; D000818:Animals; D001835:Body Weight; D001846:Bone Development / Q000187:drug effects; D001853:Bone Marrow / Q000473:pathology; D001842:Bone and Bones / Q000002:abnormalities / Q000187:drug effects / Q000473:pathology; D002118:Calcium / Q000378:metabolism; D002356:Cartilage / Q000187:drug effects; D003348:Cortisone / Q000008:administration & dosage / Q000009:adverse effects*; D004357:Drug Synergism; D004838:Epiphyses / Q000002:abnormalities; D005260:Female; D005333:Fetus / Q000187:drug effects; D007273:Injections, Intramuscular; D008431:Maternal-Fetal Exchange; D010012:Osteogenesis / Q000187:drug effects*; D010758:Phosphorus / Q000378:metabolism; D011247:Pregnancy; D051381:Rats; D011919:Rats, Inbred Strains; D014807:Vitamin D / Q000008:administration & dosage / Q000009:adverse effects*
D014807:Vitamin D; D010758:Phosphorus; D002118:Calcium; D003348:Cortisone